A Time of Hope: Experts on Alzheimers Drug Breakthroughs [Video]

Madhav Thambisetty at the National Institute on Aging explains the latest key scientific breakthroughs in Alzheimer’s research including lecanemab trials and beyond.

It’s an exciting time for Alzheimer’s research, according to Madhav Thambisetty, senior investigator at the National Institute on Aging. “We’ve known for years that the brains of patients with Alzheimer’s disease have build up of abnormal proteins in them. We’ve been able to study these for decades,” said Thambisetty. “But this is the very first time that we now have drugs that we can use to try and clear these proteins from the brain. From a scientific perspective, I really think this is a landmark.” 

Scientists gathered at the American Association for the Advancement of Science’s Annual Meeting in Denver, Colorado last month. The meeting theme, Toward Science Without Walls, explored interdisciplinary science and the consequences of barriers that fragment the scientific community. Regina Barber, co-host and scientist in residence for National Public Radio’s science podcast …